AAAAAA

   
Results: 1-9 |
Results: 9
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF THE DIFFERENTIATION STATE OF BASAL-CELL CARCINOMAS WITH SPECIAL INTEREST FOR INFILTRATING RELAPSINGTUMORS
Authors: BARBAUD A SIMON M PARACHE RM SERRE G
Citation: A. Barbaud et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF THE DIFFERENTIATION STATE OF BASAL-CELL CARCINOMAS WITH SPECIAL INTEREST FOR INFILTRATING RELAPSINGTUMORS, EJD. European journal of dermatology, 8(5), 1998, pp. 320-324
IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY
Authors: MIGNOTTE H LASSET C BONADONA V LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C PARACHE RM CHAUVIN F
Citation: H. Mignotte et al., IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY, International journal of cancer, 76(3), 1998, pp. 325-330
DETERMINATION OF THE MAXIMAL TUMOR NORMAL SKIN RATIO AFTER HPD OR M-THPC ADMINISTRATION IN HAIRLESS MOUSE (SKH-1) BY FLUORESCENCE SPECTROSCOPY - A NONINVASIVE METHOD/
Authors: BOSSU E AAMAR O PARACHE RM NOTTER D LABRUDE P VIGNERON C GUILLEMIN F
Citation: E. Bossu et al., DETERMINATION OF THE MAXIMAL TUMOR NORMAL SKIN RATIO AFTER HPD OR M-THPC ADMINISTRATION IN HAIRLESS MOUSE (SKH-1) BY FLUORESCENCE SPECTROSCOPY - A NONINVASIVE METHOD/, Anti-cancer drugs, 8(1), 1997, pp. 67-72
COMBINED FLOW-CYTOMETRY AND IMMUNOHISTOCHEMISTRY ANALYSES FOR THE ASSESSMENT OF NASOPHARYNGEAL CARCINOMA CELL-KINETICS BY IN-VIVO BROMODEOXYURIDINE INFUSION
Authors: MARCHAL S MARCHAL C PARACHE RM BENJAAFAR N ODDA M LECLERC A MERLIN JL ELGUEDDARRI B BEY P
Citation: S. Marchal et al., COMBINED FLOW-CYTOMETRY AND IMMUNOHISTOCHEMISTRY ANALYSES FOR THE ASSESSMENT OF NASOPHARYNGEAL CARCINOMA CELL-KINETICS BY IN-VIVO BROMODEOXYURIDINE INFUSION, Cytometry, 29(2), 1997, pp. 165-172
COMPARATIVE-EVALUATION OF QUANTITATIVE IM MUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAYS FOR HORMONE RECEPTORS IN BREAST-CANCER
Authors: MARCOT I MIGEON C PARACHE RM MARCHAL S VIRION JM
Citation: I. Marcot et al., COMPARATIVE-EVALUATION OF QUANTITATIVE IM MUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAYS FOR HORMONE RECEPTORS IN BREAST-CANCER, Bulletin du cancer, 84(6), 1997, pp. 613-618
SENSITIVITY TO TAXOID DERIVATIVES OF A NEWLY ESTABLISHED HUMAN ENDOMETRIOID OVARIAN ADENOCARCINOMA RADIORESISTANT CELL-LINE
Authors: GRIFFON G MERLIN JL PARACHE RM MARTINET N MARCHAL S NABET F WELLMAN M BARLIER C MARCHAL C
Citation: G. Griffon et al., SENSITIVITY TO TAXOID DERIVATIVES OF A NEWLY ESTABLISHED HUMAN ENDOMETRIOID OVARIAN ADENOCARCINOMA RADIORESISTANT CELL-LINE, Anticancer research, 16(1), 1996, pp. 177-187
RADIOSENSITIVITY OF MULTICELLULAR TUMOR SPHEROIDS OBTAINED FROM HUMANOVARIAN CANCERS
Authors: GRIFFON G MARCHAL C MERLIN JL MARCHAL S PARACHE RM BEY P
Citation: G. Griffon et al., RADIOSENSITIVITY OF MULTICELLULAR TUMOR SPHEROIDS OBTAINED FROM HUMANOVARIAN CANCERS, European journal of cancer, 31A(1), 1995, pp. 85-91
EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN MAM MARY PAGETS-DISEASE - IMMUNOHISTOCHEMICAL STUDY BY USING 3 DIFFERENT ANTIBODIES
Authors: EDORH A PARACHE RM MIGEON C NSOSSANI B RIHN B
Citation: A. Edorh et al., EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN MAM MARY PAGETS-DISEASE - IMMUNOHISTOCHEMICAL STUDY BY USING 3 DIFFERENT ANTIBODIES, Pathologie et biologie, 43(7), 1995, pp. 584-589
DETERMINATION OF AMPLIFICATION LEVEL OF THE C-ERBB-2 PROTOONCOGENE INHUMAN BREAST CARCINOMAS - A COMPARATIVE-STUDY BETWEEN NONRADIOACTIVE AND RADIOACTIVE LABELING
Authors: EDORH A PARACHE RM NSOSSANI B BOTTIN MC MERLIN JL COLOSETTI P GUILLEMIN F LEFAOU A RIHN B
Citation: A. Edorh et al., DETERMINATION OF AMPLIFICATION LEVEL OF THE C-ERBB-2 PROTOONCOGENE INHUMAN BREAST CARCINOMAS - A COMPARATIVE-STUDY BETWEEN NONRADIOACTIVE AND RADIOACTIVE LABELING, Cellular and molecular biology, 41(7), 1995, pp. 967-973
Risultati: 1-9 |